Atlas Trials

Prognostic Value of Neonatal Markers for the Development of Neurosensorial Sequelae in Children Infected by Cytomegalovirus in Utero

Clinical trial NCT01923636 · COMPLETED

Trial details

NCT number
NCT01923636
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Congenital Cytomegalovirus Infection
Start date
2013-09-09
Primary completion
2021-01-30
Enrollment
254

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.